Emerging Viral Diseases

  title={Emerging Viral Diseases},
  author={James W. Le Duc and Neal Nathanson},
  journal={Viral Pathogenesis},
  pages={215 - 231}

Figures and Tables from this paper

Cholesterol‐conjugated peptide antivirals: a path to a rapid response to emerging viral diseases†

  • A. Pessi
  • Biology
    Journal of peptide science : an official publication of the European Peptide Society
  • 2015
While it is now possible to identify and genetically fingerprint the causative agents of emerging viral diseases, often with extraordinary speed, suitable therapies cannot be developed with


This review has compiled with clear information’s about viruses which are highly affected in India in 19-21 century with the most important past, present viral outbreaks in India.

The Impact and Control of Emerging and Re-Emerging Viral Diseases in the Environment: An African Perspective

The features of common emergent viruses and factors facilitating their emergence, effects, control and sustained management in the environment are outlined.

(2013) Current progress with serological assays for exotic emerging / re-emerging viruses. Future Virology, 8 (8). pp. 745-755.

This review details ‘next-generation’ assays aimed at addressing some of the persistent problems with viral serology, focusing on how manipulating the genomes of RNA viruses can produce attenuated or chimeric viruses that can be exploited as surrogate viruses in neutralization assays.

Assessing drug repurposing option for emerging viral diseases: concerns, solutions, and challenges for forthcoming viral battles

To contain outbreaks and prevent transmissions, the lack of data on novel pathogens has frequently come in the way of action and there is no effective, adequate treatment till date for the majority, which calls for an immediate need to produce an antiviral cure.

Structural Vaccinology for Viral Vaccine Design

This review focuses on recent advances in structure-based vaccine design, or structural vaccinology, for novel and innovative viral vaccine design.

Dynamics of avian coronavirus circulation in commercial and non-commercial birds in Asia – a review

The present review provides an overview ofIBV circulation and the dynamic emergence of new variants found throughout Asia via the recombination of IBV strains.



Emerging virus diseases: can we ever expect the unexpected?

This review summarizes recent work on aspects of virus emergence and the current understanding of the molecular and immunological basis whereby viruses may cross between species and become established in new ecological niches.

Infectious diseases. MERS surges again, but pandemic jitters ease.

The number of infections of the deadly Middle East respiratory syndrome virus surges again in Saudi Arabia, but scientists are less worried that the virus will cause a pandemic than they were 3 years

Enhanced virulence of influenza A viruses with the haemagglutinin of the 1918 pandemic virus

It is demonstrated that the HA of the 1918 virus confers enhanced pathogenicity in mice to recent human viruses that are otherwise non-pathogenic in this host.

Ebola virus vaccines: an overview of current approaches

DNA, subunit and several viral vector approaches, replicating and non-replicating, have been tested as potential vaccine platforms and their protective efficacy has been evaluated in nonhuman primate models for Ebola virus infections, which closely resemble disease progression in humans.

Mission to MERS.

An unusual collaboration of scientists from Qatar and the Netherlands has collected thousands of samples at Qatari farms, a camel market, and a slaughterhouse to address issues related to the spread of the Middle East respiratory syndrome.

Infectious Diseases. A reassuring snapshot of Ebola.

Ebola virus genome sequences of four recent Ebola virus samples suggest that the virus, so far, has remained fairly stable.

Genetic identification of a hantavirus associated with an outbreak of acute respiratory illness.

A mysterious respiratory illness with high mortality was recently reported in the southwestern United States and nucleotide sequence analysis revealed the associated virus to be a new hantavirus and provided a direct genetic link between infection in patients and rodents.

Middle East respiratory syndrome coronavirus (MERS-CoV): evidence and speculations

The current state of knowledge regarding the virology, clinical spectrum, evolution, diagnosis and treatment of MERS-CoV infections is reviewed.

A decade after SARS: strategies for controlling emerging coronaviruses

The emergence and identification of novel human coronaviruses over the past 10 years are described, their key biological features are discussed, including tropism and receptor use, and approaches for developing broadly effective vaccines are summarized.

AIDS as a zoonosis: scientific and public health implications.

Evidence of simian immunodeficiency virus (SIV) infection has been reported for 26 different species of African nonhuman primates and the implications of human infection by a diverse set of SIVs and of exposure to a plethora of additional human immunodewirable viruses are discussed.